| payload |
{"created_at":"2026-04-05T15:04:41.111 {"created_at":"2026-04-05T15:04:41.111260+00:00","dedupe_key":"opportunity_case_memory:case_eb0c9a65a5e70ab0:monitor:2026-04-05T15","evidence_event_ids":["evt_7780a5a608da","evt_fbbeffd652c9","evt_2003a2d7a61b"],"reason_trace":{"case_id":"case_eb0c9a65a5e70ab0","decision":"monitor","entity_key":"equity:NKTR","memory_only":true,"theme_key":"entity_development"},"severity":"low","signal_type":"opportunity_case_memory","source":"opportunity_finder","throttle_s":3600,"value":{"case_id":"case_eb0c9a65a5e70ab0","confidence":0.32,"corroboration":{"agreement":{"count_score":0.5,"down_count":0,"magnitude_weighted_score":0.5,"majority_direction":"neutral","neutral_count":3,"score":0.5,"up_count":0},"base_score":0.5754,"claim_graph":{"case_signal_families":["market","research"],"case_source_domains":["themalaysianreserve.com","wisconsinpoliticalbrief.com"],"claims":[{"agreement_score":0.6,"claim_id":"claim_8db919cd19c69ec3","conflict":false,"direction":"neutral","evidence_count":2,"family_coverage":1,"quality_score":0.4413,"source_coverage":1,"source_trust":0.58,"statement":"NKTR SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 - The Malaysian Reserve","strength":0.543},{"agreement_score":0.6,"claim_id":"claim_3f9086c8bbbbc5a7","conflict":false,"direction":"neutral","evidence_count":1,"family_coverage":1,"quality_score":0.3963,"source_coverage":1,"source_trust":0.58,"statement":"Nektar Therapeutics is facing a federal securities fraud class action lawsuit due to alleged misleading statements by its executives.","strength":0.6}],"coverage":{"claim_count":2,"conflicting_claims":0,"dominant_claim_id":"claim_8db919cd19c69ec3","multi_family_claims":0,"multi_source_claims":0},"score":0.3275},"contradiction":{"flags":[],"has_unresolved_conflict":false,"resolved_claims":[],"resolved_count":0,"score":0.0,"unresolved_claims":[],"unresolved_count":0},"contradiction_flags":[],"evidence_event_count":3,"high_precision_pass":false,"high_trust_source_coverage":0,"independent_source_coverage":2,"low_trust_source_coverage":0,"score":0.507,"signal_family_coverage":2,"source_trust":{"avg_score":0.58,"domains":[{"count":2,"domain":"themalaysianreserve.com","score":0.58,"source":"The Malaysian Reserve"},{"count":1,"domain":"wisconsinpoliticalbrief.com","score":0.58,"source":"web_search"}],"high_trust_domains":[],"independent_high_trust_sources":2,"low_trust_domains":[]},"source_trust_score":0.377},"decision":"monitor","entity_key":"equity:NKTR","evidence_event_count":3,"headline":"Nektar Therapeutics is facing a federal securities fraud class action lawsuit due to alleged misleading statements by its executives.","personal_relevance_score":0.1,"theme_key":"entity_development","why_now":"Signal convergence: Nektar Therapeutics is facing a federal securities fraud class action lawsuit due to alleged misleading statements by its executives. [neutral]; NKTR SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds..."}}... |